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Abstract
Introduction:  Elective  neck  dissection  is  recommended  in  cases  of  oral  cavity  squamous  cell
carcinoma  without  lymph  node  metastasis  because  of  the  risk  of  occult  metastasis.
Objective:  The  present  study  aimed  to  evaluate  predictive  factors  for  occult  lymph  node  metas-
tasis in  patients  with  oral  cavity  squamous  cell  carcinoma  treated  with  elective  neck  dissection
and their  impact  on  overall  and  disease-free  survival.
Methods:  Forty  surgically  treated  patients  were  retrospectively  included.
Results: Ten  cases  (25%)  had  lymphatic  metastasis.  Of  the  studied  variables,  perineural  and
angiolymphatic  invasion  in  addition  to  tumor  thickness  were  statistically  associated  with  lymph
node metastasis.  Only  angiolymphatic  invasion  was  identiﬁed  as  an  independent  risk  factor
for occult  metastasis  in  the  logistic  regression  (OR  =  39.3;  p  =  0.002).  There  was  no  association
between  overall  and  disease-free  survival  with  the  presence  of  occult  lymph  node  metastasis.
Conclusion:  Metastatic  disease  rate  was  similar  to  that  found  in  the  literature.  Perineural  and
angiolymphatic  invasion  and  tumor  thickness  were  associated  with  occult  metastasis,  but  only
angiolymphatic  invasion  showed  to  be  an  independent  risk  factor
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Carcinoma  espinocelular  da  cavidade  oral:  fatores  relacionados  à  presenc¸a  de
metástases  linfonodais  ocultas
Resumo
Introduc¸ão:  O  esvaziamento  cervical  eletivo  é  realizado  de  maneira  sistemática  nos  casos  de
carcinoma espinocelular  da  cavidade  oral  sem  linfonodos  clinicamente  comprometidos  devido
à alta  incidência  de  metástases  ocultas.
Objetivo:  Avaliar  pacientes  com  carcinoma  espinocelular  de  cavidade  oral  tratados  com  esvazi-
amento cervical  eletivo  quanto  a  fatores  preditivos  para  ocorrência  de  metástases  ocultas  e  o
impacto das  mesmas  na  sobrevivência  global  e  livre  de  progressão  destes  pacientes.
Método: Quarenta  pacientes  cirurgicamente  tratados  foram  avaliados  em  estudo  retrospectivo.
Resultados:  Dez  casos  (25%)  apresentaram  metástases  ocultas.  Das  variáveis  analisadas,  invasão
perineural  e  angiolinfática  e  também  a  espessura  tumoral  foram  estatisticamente  signiﬁcantes
à análise  univariada.  Apenas  a  invasão  angiolinfática  foi  fator  independente  de  risco  de  metás-
tases ocultas  pela  regressão  logística  (OR  =  39,3;  p  =  0,002).  A  presenc¸a  de  metástase  oculta  não
apresentou  diferenc¸a  estatisticamente  signiﬁcante  em  relac¸ão  às  taxas  de  sobrevivência  global
e livre  de  progressão.
Conclusão:  A  incidência  de  metástase  oculta  foi  semelhante  à  literatura.  A  invasão  perineural,
angiolinfática  e  a  espessura  tumoral  foram  fatores  associados  à  presenc¸a  de  metástase  oculta,
porém apenas  a  invasão  angiolinfática  apresentou-se  como  um  fator  de  risco  independente  para
ocorrência do  fenômeno.
©  2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publicado  por
Elsevier Editora  Ltda.  Todos  os  direitos  reservados.
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2Introduction
Squamous  cell  carcinoma  is  the  most  common  histological
type  of  cancer  of  the  oral  cavity,  and  has  an  important
and  well-established  pattern  of  dissemination  to  cervical
lymph  nodes.1 Even  in  patients  clinically  without  evidence
of  metastatic  lymph  nodes  (N0),  elective  neck  dissection  in
conjunction  with  resection  of  the  primary  tumor,  is  part  of
the  standard  treatment  of  the  disease  because  the  risk  of
occult  metastasis  is  greater  than  20%.1--6
Several  studies  have  tried  to  assess  factors  that  would
predict  occult  metastases  and  their  inﬂuence  on  survival
rates,  such  as  tumor  thickness,  perineural  invasion  and  angi-
olymphatic  invasion.1,7--10 In  attempts  to  reduce  surgical
morbidity,  some  have  proposed  alternatives  to  elective  neck
dissection,  such  as  sentinel  lymph  node  mapping11,12 and
even  avoiding  any  surgical  approach  to  the  neck  in  selected
cases;13,14 the  latter  has  the  poorest  survival  results.5,15,16
Thus,  elective  neck  dissection  currently  remains  the  most
widely  used  treatment.
The  present  study  aimed  to  evaluate  the  risk  of  the
presence  of  occult  lymph  node  metastases  in  patients  with
squamous  cell  carcinoma  of  the  oral  cavity  submitted  to
resection  and  elective  neck  dissection,  in  order  to  identify
factors  related  to  the  development  of  nodal  metastases,
and  to  identify  its  impact  on  overall  and  disease-free
survival.Method
This  was  a  longitudinal  historical  cohort  study  that,  after
approval  by  the  Ethics  Committee  of  Institutional  Research
3nder  No.  507/11,  retrospectively  assessed  electronic  medi-
al  records  of  consecutive  patients  submitted  to  primary
umor  resection  with  intent  to  cure  combined  with  elective
eck  dissection  in  patients  with  oral  cavity  squamous  cell
arcinoma  (including  the  lip).  Forty  patients  were  selected
rom  April  of  2009  (beginning  of  the  Head  and  Neck  Surgery
ervice)  until  December  of  2012.
Inclusion  criteria  consisted  of  cases  of  squamous  cell  car-
inoma  of  the  oral  cavity,  whose  initial  treatment  was  a
urgical  procedure  with  primary  lesion  resection  and  elec-
ive  unilateral  or  bilateral  neck  dissection,  depending  on  the
esion  location,  with  all  patients  being  considered  N0  at  clin-
cal  examination  and  preoperative  imaging  tests.  Neoplasms
n  other  sites  than  the  oral  cavity  were  excluded,  as  well  as
ther  histological  types,  patients  who  had  suspected  lymph
ode  detected  intraoperatively,  leading  to  conduct  change
nto  radical  dissection,  and  patients  submitted  to  previous
urgical  treatment  or  chemotherapy  and/or  radiotherapy,
ven  for  neoplasms  located  at  another  site  in  the  head  and
eck.
Patients  were  assessed  regarding:
.  Demographic  data:  gender  and  age;
.  Clinical  data:  primary  tumor  location  (for  this  variable,
major  oral  cavity  subsites  were  divided  into  tongue,  ﬂoor
of  the  mouth,  retromolar  area,  lip,  buccal  mucosa,  and
alveolar  border).  Patients  were  only  included  with  squa-
mous  cell  carcinoma  of  the  lip  when  it  extended  to
the  buccal  mucosa,  justifying  elective  neck  dissection
according  to  the  institutional  protocol;
.  Anatomopathological  data:  pT  stage  (analyzed  in  inde-
pendent  subgroups  and  also  in  pT1  and  pT2  vs.  pT3
2 d’Alessandro  AF  et  al.
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Table  1  Demographic,  clinical,  and  anatomopathological
data (n  =  40).
Variable  Absolute
frequency
Relative
frequency  (%)
Gender
Male  35  87.5
Female  5  12.5
Subsite
Tongue  15  37.5
Floor  of  the  mouth 11  27.5
Retromolar  area 7  17.5
Buccal  mucosa  or  lip  with
buccal  extension
6  15.0
Alveolar  border  1  2.5
Anatomopathological  24  60.0
Perineural  invasion 9  22.5
Angiolymphatic  invasion 24  63.2
Tumor  thickness  >7  mm
(n =  38)a
35  87.5
Free  margins 13  32.5
pT 9  22.5
pT1 4  10.0
pT2 14  35.0
pT3 30  75.0
pT4a  4  10.0
pN 6  15.0
pN0 3  30.0
pN1 12  30.0
pN2b  7  17.5
Extracapsular  leakage
(n  =  10)
5  12.5
Stage  16  40.0
I
II
III
IVa
Follow-up  2  5.0
Second  primary  tumor  21  52.5
Adjuvant  treatment  14  35.0
Isolated  radiotherapy  7  17.5
Chemoradiation  9  22.5
Recidivism  8  20.0
Locoregional  4  10.0
Distant  metastasis  9  22.5
Death
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and  pT4a  and  pT1--pT3  vs.  pT4a  stratiﬁcation),  primary
tumor  thickness  (in  mm),  presence  or  absence  of  per-
ineural  and  angiolymphatic  invasion,  surgical  margins,
pN  stage,  number  of  lymph  nodes  in  pN+  cases,  pres-
ence  or  absence  of  capsular  leakage  in  metastatic  lymph
nodes,  and  anatomopathological  stage  per  groups  (I--IV)
according  to  the  classiﬁcation  of  American  joint  Commit-
tee  on  Cancer/Union  for  International  Cancer  Control,
UICC/AJCC  (7th  edition,  2010);
.  Surgical  data:  related  to  the  performed  neck  dissection;
.  Adjuvant  treatments  performed:  radiotherapy  and/or
chemotherapy;
.  Development  of  locoregional  recurrence,  distant  metas-
tasis,  and  second  primary  tumor,  as  well  as  time  of
occurrence  of  these  events;
. Follow-up  time  in  months,  requiring  a  minimum  of  12
months  for  patients  who  did  not  die  during  this  period;
.  Most  recent  oncological  status  (alive  and  disease-free,
alive  with  the  disease,  asymptomatic  dead,  and  dead  due
to  cancer).
Statistical  analysis  was  performed  as  described  below.
he  values  obtained  by  the  study  of  each  continuous  vari-
ble  were  organized  and  expressed  as  mean  and  standard
eviation,  whereas  qualitative  variables  were  expressed  as
bsolute  and  relative  frequencies.  Sample  distribution  was
eﬁned  as  parametric  using  the  Kolmogorov--Smirnov  test.
omparisons  of  the  frequency  of  a  phenomenon  between
roups  of  qualitative  variables  were  performed  using  Fisher’s
xact  test  or  the  chi-squared  test.  The  comparison  between
he  means  of  a  continuous  variable  with  parametric  distri-
ution  between  two  groups  was  performed  using  Student’s
-test.  The  logistic  regression  model  was  used  in  the  multi-
ariate  analysis,  establishing  values  of  odds  ratio  (OR)  and
5%  conﬁdence  interval  (95%  CI).
The  Kaplan--Meier  method  was  used  for  survival  analysis
nd  comparison  of  groups  was  performed  using  the  log-rank
est.  All  analyses  were  performed  using  Statistical  Package
or  the  Social  Sciences,  (SPSS  statistical  software),  version
7.0  (SPSS  Inc  --  Illinois,  USA),  with  a  signiﬁcance  level  of  5%
p  < 0.05).
esults
f  the  40  patients,  35  (87.5%)  were  males  and  mean  age  was
0  years  (minimum  40  and  maximum  of  89  years,  standard
eviation  of  12.9  years).
The  most  often  affected  subsites  were  the  tongue  and
he  ﬂoor  of  the  mouth  (65%)  and  there  was  a  predominance
f  advanced  stages  (stages  III  and  IV  =  52.5%).  As  for  the
istological  characteristics  of  primary  tumors,  mean  tumor
hickness  was  1.4  ±  1.2  cm;  in  ﬁve  cases  (12.5%)  the  ﬁnal  sur-
ical  margins  were  considered  involved;  24  tumors  (60%)  had
erineural  invasion  and  nine  (22.5%)  showed  angiolymphatic
nvasion.  Mean  follow-up  was  18  months  and  nine  cases  of
isease  progression  were  identiﬁed  (ﬁve  exclusively  locore-
ional  recurrences,  one  case  of  pulmonary  metastasis  with
ontrolled  primary  site  and  neck,  and  three  patients  with
oth)  and  more  than  half  of  the  patients  (52.5%)  required
djuvant  treatment.  The  descriptive  data  of  the  entire
eries  are  shown  in  Table  1.
d
a
t
oa Thickness: mean ± standard deviation = 1.4 ± 1.2 cm.
Regarding  the  analysis  of  neck  dissection,  14  patients
nderwent  bilateral  surgery,  as  the  primary  tumor  surpassed
he  anatomical  midline,  totaling  54  dissections.  The  mean
umber  of  dissected  lymph  nodes  was  27.2  ±  11.4.  Most
ases  (87.5%)  underwent  dissection  at  levels  I,  II,  and  III,
ut  ﬁve  patients  were  submitted  to  level  IV  dissection
ue  to  intraoperative  decision  of  the  attending  surgeon,
nd  there  were  no  occult  metastases  to  lymph  nodes  at
hat  level  in  any  of  these  cases.  Ten  patients  (25.0%)  had
ccult  lymph  node  metastases  in  the  anatomopathological
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Table  2  Univariate  analysis  of  factors  related  to  the  pres-
ence of  occult  lymph  node  metastasis.
Comparison  Lymph  node
metastasis/total  (%)
p
Gender  1.000a
Male  9/35  (25.7)
Female  1/5  (20.0)
Ageb 0.240b
Absence  of  lymph  node
metastasis
61.5  ±  12.5
Presence  of  lymph  node
metastasis
58.2  ±  14.4
Subsite  0.544c
Tongue  2/15  (13.3)
Floor  of  the  mouth  4/11  (36.4)
Retromolar  area  3/7  (42.9)
Lip 1/4  (25.0)
Buccal  mucosa  0/2  (0.0)
Alveolar  border  0/1  (0.0)
Perineural  invasion 0.032a
No  1/16  (6.3)
Yes 9/24  (37.5)
Angiolymphatic  invasion  <0.0001a
No  3/31  (9.7)
Yes 7/9  (77.8)
Tumor  thickness  >7  mm  0.043a
No  1/14  (7.1)
Yes 9/24  (37.5)
pTd Stage  0.230c
pT1  1/13  (7.7)
pT2 2/9  (22.2)
pT3  2/4  (50.0)
pT4a  5/14  (35.7)
a Fisher’s exact test.
b Comparison between means of age -- Student’s t-test.
c Chi-squared test.
d Note: no statistically signiﬁcant difference was observed
between the stratiﬁed pT stage and the presence of occult lymph
Table  3  Multivariate  analysis  of  risk  factors  for  the  pres-
ence of  occult  lymph  node  metastasis.
Factor  OR  95%  IC  pa
Presence  of  angiolymphatic
invasion
39.3  3.7--420.9  0.002
Presence  of  perineural
invasion
1.5  0.1--23.7  0.766
n
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calculation  of  power  of  the  main  estimate  performed  (angi-node metastasis (p = 0.274 and p = 0.278, respectively for pT1
and pT2 vs. pT3 and pT4a, and pT1--pT3 vs. pT4a).
assessment  (Table  1),  and  none  of  the  patients  undergoing
bilateral  neck  dissection  had  N2c  stage.
The  variable  tumor  thickness  was  submitted  to  ROC  curve
analysis,  and  it  was  determined  that  the  best  cutoff  for  risk
stratiﬁcation  of  occult  lymph  node  metastases  was  >7  mm
(area  under  the  ROC  curve  of  68.2%;  95%  CI:  50.3%--86.1%).
The  univariate  analysis,  detailed  in  Table  2,  showed  that
the  presence  of  perineural  invasion  (p  =  0.032;  Fisher’s  exact
test),  angiolymphatic  invasion  (p  <  0.0001;  Fisher’s  exact
test),  and  tumor  thickness  >7  mm  (p  =  0.043;  Fisher’s  exact
test)  were  factors  related  to  the  presence  of  occult  lymph
node  metastases.
Variables  with  p  <  0.20  in  the  univariate  analysis  were
submitted  to  a  logistic  regression  model,  shown  in  Table  3.
It  was  veriﬁed  that  angiolymphatic  invasion  was  the  only
independent  risk  factor  for  the  presence  of  occult  lymph
o
p
dTumor thickness  >7  mm  11.6  0.7--204.3  0.093
a Logistic regression.
ode  metastasis  (OR  =  39.3;  95%  CI:  3.7--420.9;  p  =  0.002).
s  this  was  a  retrospective  study,  the  calculation  of  power
or  this  estimate  was  conducted  during  the  analysis,  using
he  method  for  cohort  studies.  Considering  the  OR  of  39.3
nd  the  proportion  of  25%  of  occult  lymph  node  metastases
n  this  group,  the  inclusion  of  40  patients  determined  that
his  estimate  demonstrated  power  >90%.
Survival  analysis  showed  that  disease-free  survival  and
verall  cumulative  survival  (Figure  1) were  68.2%  and  64.1%,
espectively.  Even  though  there  was  no  statistically  signiﬁ-
ant  difference,  patients  with  occult  lymph  node  metastases
howed  a  lower  disease-free  survival  rate,  a  lower  overall
urvival,  and  a  median  survival  of  28  months  in  the  ﬁnal
nalysis,  compared  to  patients  without  this  factor  (Table  4;
igure  2).
iscussion
he  presence  of  occult  metastases  in  squamous  cell  car-
inoma  of  the  oral  cavity  is  very  prevalent  due  to  its
ggressiveness1 and  neck  treatment  is  mandatory,  even
n  cases  without  clinical  signs  of  involvement.  Surgical
reatment  has  an  advantage  over  radiotherapy,  since  it
stablishes  the  patient’s  complete  pathological  staging,  pre-
enting  unnecessary  use  of  radiotherapy  in  some  cases.17
This  sample  showed  a  prevalence  of  male  patients,  with
ost  tumors  located  in  the  tongue  and  ﬂoor  of  the  mouth,
onsistent  with  the  literature.3,7,16 The  presence  of  occult
etastases  in  25%  of  cases  was  in  agreement  with  other
tudies.1,3,4,18 With  regard  to  all  cases  with  positive  neck
nvolvement,  it  is  noteworthy  that  three  cases  had  metas-
asis  in  more  than  one  cervical  level,  and  in  three  cases  the
etastases  were  stages  II  and/or  III,  with  level  I disease-
ree.  No  patient  had  level  IV  involvement.  This  shows  that
lthough  some  cases  of  skip  metastases  occurred,  dissection
t  levels  I--III  would  have  been  sufﬁcient  treatment  for  all
atients  in  this  series.
However,  some  authors  have  reported  3--28%  of  affected
ymph  nodes  at  level  IV,  especially  in  tongue  and  ﬂoor-
f-the-mouth  tumors,  but  studies  have  disagreed  about
lective  dissection  extension  to  level  IV  in  the  oral  cavity
umors,  with  most  of  them  favoring  the  non-extension.19--22
t  is  noteworthy  that  the  present  study  included  40  con-
ecutive  patients,  which  at  ﬁrst  may  be  considered  a
mall  sample  and  a  limitation  of  the  study;  however,  thelymphatic  invasion  as  an  independent  risk  factor  for  the
resence  of  occult  lymph  node  metastasis)  was  >90%,  which
emonstrates  the  statistical  signiﬁcance  of  the  ﬁndings.
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Figure  1  Kaplan--Meier  Curves.  (A)  Cumulative  disease-free  survival  of  68.2%;  (B)  Cumulative  overall  survival  of  64.1%.
Table  4  Analysis  of  overall  and  disease-free  survival.
Variable  Events/total  Accumulated  survival  (%)  pa
Disease-free  survival  0.587
Absence of  lymph  node  metastasis  6/30  71.4
Presence of  lymph  node  metastasis  3/10  60.0
Overall survival  0.248
Absence of  lymph  node  metastasis  5/30  80.4
Presence of  lymph  node  metastasis  4/10  40.0b
f
i
c
F
d
l
ma Log-rank test.
b Median of survival attained at 28 months.In  the  many  existing  studies,  the  major  risk  factors
or  occult  metastases  are  angiolymphatic  invasion,  per-
neural  invasion,  and  tumor  thickness.1,2,4,8,9,17,19 This  was
orroborated  by  the  present  study,  but  only  angiolymphatic
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igure  2  Kaplan--Meier  curves  comparing  the  groups  with  absence
isease-free  survival  of  71.4%  and  60.0%,  respectively,  for  the  absen
og-rank test);  (B)  Cumulative  overall  survival  of  80.4%  and  40.0%,  re
etastases (p  =  0.248  --  log-rank  test).nvasion  was  shown  to  be  an  independent  risk  factor  of
ccult  metastases.
Although  studies  increasingly  focus  on  these  characteris-
ics  as  predictors  of  lymphatic  dissemination,  from  a  clinical
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ROccult  lymph  node  metastasis  and  oral  SCC  
point  of  view,  except  for  thickness,  all  are  factors  that  are
inaccessible  until  tumor  resection  and  therefore  may  not  be
used  for  decision-making,  such  as  not  treating  the  neck  or
using  less  invasive  treatments  such  as  sentinel  lymph  node
technique.  When  positron  emission  tomography-computed
tomography  (PET-CT),  which  has  been  increasingly  used  and
studied,  is  negative  for  the  neck,  it  is  considered  enough
evidence  to  justify  expectant  conduct,  but  the  patient  sam-
ples  evaluated  were  few  and  follow-up  was  not  long  enough
to  evaluate  survival  or  morbidities  when  salvage  neck  dis-
section  is  employed.19,23
The  sentinel  lymph  node  (SLN)  technique  for  the  treat-
ment  of  N0  patients  has  been  studied  since  the  1990s.  It  has
similar  rates  to  elective  neck  dissection  for  the  detection  of
occult  metastases.24,25 A  European  multicenter  study  com-
pared  two  groups,  one  using  the  sentinel  lymph  node  and  one
with  systematic  extension  to  selective  neck  dissection  with  a
follow-up  of  ﬁve  years;  it  found  cervical  recurrence  in  three
cases  considered  negative  in  the  SLN  arm  but  no  recurrence
in  the  other  group.24 It  also  showed  difference  in  disease-
free  survival,  but  without  statistical  signiﬁcance.24 Another
European  study  with  follow-up  of  10  years,  in  which  SLN  was
carried  out  without  systematic  neck  dissection  in  53  cases
from  a  total  of  174,  showed  method  failure  rate  of  4.8%,
with  negative  predictive  value  of  95.2%,  considered  by  the
author  similar  to  that  of  elective  neck  dissection.25
Tumor  thickness  has  been  widely  studied  as  a  predic-
tor  of  cervical  lymph  node  metastases  in  patients  with
squamous  cell  carcinoma  of  the  upper  aerodigestive  tract,
especially  because  up  to  40%  of  patients  with  these  tumors
exhibit  occult  metastases.26 Huang  et  al.27 performed  a
meta-analysis  analyzing  tumor  thickness  and  the  risk  of  cer-
vical  lymph  node  metastasis.  They  concluded  that  a  4-mm
cutoff  for  tumor  thickness  would  be  a  strong  predictor  of
the  presence  of  occult  cervical  lymph  node  metastasis;  they
found  a  rate  of  16.6%  among  patients  with  tumor  thickness
>4  mm,  compared  to  4.5%  among  those  with  tumor  thickness
≤4  mm.
Fukano  et  al.28 studied  34  patients  with  tongue  carcinoma
treated  with  early  surgical  resections  without  preoperative
therapy.  Mean  tumor  thickness  was  6.4  mm  (0--18.2  mm)  and
64.7%  of  patients  with  tumor  thickness  >5  mm  had  lymph
node  metastases,  compared  to  5.9%  of  patients  with  thick-
ness  <5  mm.  The  present  study  established  a  cut-off  of  7  mm
as  a  predictor  of  occult  neck  metastases,  established  by
the  ROC  curve  analysis.  This  index,  slightly  higher  than  that
found  in  the  literature,  is  probably  due  to  the  fact  that  the
present  study  was  performed  in  a  public  institution,  in  which
patients  present  with  more  advanced  neoplasms  at  the  ini-
tial  diagnosis.  The  mean  tumor  thickness  was  14  mm  and  45%
of  patients  had  pT3  and  pT4a  tumors,  which  unfortunately
is  comparable  to  most  Brazilian  oncological  institutions,  and
one  of  the  limitations  for  comparison  of  results,  especially
with  international  case  series.
This  study  also  documented  a  small  proportion  of  occult
metastases  in  patients  with  pT1  or  pT2  stage  (17.4%),  but
this  result  is  similar  to  that  found  in  the  literature.  Kelner
et  al.29 found  rates  of  12.5%  and  22.4%  for  the  incidence  of
lymph  node  metastases  in  patients  with  squamous  cell  carci-
noma  of  the  oral  cavity  that  were  respectively  pT1  and  pT2
(20.5%  when  the  stages  were  added).  Thus,  Poonacha  and
Go30 question  whether  elective  neck  dissection  should  be253
erformed  in  this  population  despite  the  recommendation
f  the  American  protocol.
Pathological  features  are  valuable  for  indication  of  adju-
ant  treatment  with  radiotherapy  and/or  chemotherapy,  as
atients  with  known  presence  of  cervical  metastases  have
ower  survival  rates,  especially  disease-free  survival,  com-
ared  to  patients  without  neck  involvement.  The  overall  and
isease-free  survival  curves  shown  in  this  study  demonstrate
he  effect  of  the  presence  of  lymph  node  involvement  on  dis-
ase  evolution;  even  when  the  involvement  is  microscopic,
he  necessary  adjuvant  therapy  is  performed.  However,
hese  patients  have  lower  overall  and  disease-free  survival
ates  than  patients  with  tumors  conﬁned  to  the  primary  site.
The  fact  that  the  oncological  follow-up  period  of  ﬁve
ears  has  yet  to  be  completed  is  a  limitation  of  this  study.
his  occurred  because  the  Institute  opened  in  2009;  how-
ver,  the  authors  believe  that  this  fact  has  little  inﬂuence  on
urvival  analysis.  It  is  well  known  in  the  literature  that  tumor
ecurrence  occurs  mainly  in  the  ﬁrst  year  of  follow-up.
into  et  al. 31 found  that  92.8%  of  locoregional  recurrence
ccurred  within  the  ﬁrst  12  months  of  follow-up  in  patients
ith  squamous  cell  carcinoma  of  the  oral  cavity  and  orophar-
nx.
onclusions
his  study  demonstrated  that  the  incidence  of  occult  metas-
ases  in  squamous  cell  carcinoma  of  the  oral  cavity  was  25%
n  a  population  consisting  of  45%  pT3  and  pT4a  patients.
mong  the  factors  evaluated,  perineural  and  angiolymphatic
nvasion  and  tumor  thickness  >7  mm  were  associated  with
he  presence  of  occult  neck  metastases,  but  only  angiolym-
hatic  invasion  proved  to  be  an  isolated  risk  factor  for  the
ccurrence  of  the  event.  Disease-free  survival  and  overall
urvival  in  the  two  groups  exhibited  differences,  although
hey  were  not  statistically  signiﬁcant.
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